Login
Seer, Inc. logo

Seer, Inc.

seer.bio

What Do They Do?

Sells an integrated system of consumable assays, an automation instrument and software that helps academic and biopharmaceutical researchers study proteins in biological samples.

How Do They Make Money?

Customers buy instruments and consumables; payment is typically due within 30 or 60 days after shipment. For data-generation and analysis services, Seer bills when it delivers the report, with payment typically due within 30 or 60 days.

FY2025 revenue

Who Are Their Customers?

Academic and commercial research laboratories, biopharmaceutical companies and biotechnology companies buy the Proteograph. Seer sells directly in the United States and through both direct sales and distributors outside the United States.

Do Revenues Turn Into Profits?

No. It lost $73.6M in FY2025.

Operating income, FY2025
−470% of revenue
▲ +22% (Loss) vs FY2024 (−$100.1M, −706%)
Net income, FY2025
−444% of revenue
▲ +15% (Loss) vs FY2024 (−$86.6M, −611%)
Free cash flow, FY2025
−279% of revenue
▲ +7% (Loss) vs FY2024 (−$49.7M, −351%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −3%
vs $4.1M in Q3 FY2025
Net income
▲ +25% (Loss)
vs −$18.2M in Q3 FY2025
  • Nov 10, 2026 Updates full-year 2026 revenue guidance to $13.5 million to $14.5 million
  • Oct 29, 2026 Special committee rejects acquisition proposals; Seer remains independent The committee rejected both unsolicited proposals to acquire Seer, concluding they did not reflect its value.
  • Sep 14, 2026 Chief financial officer David Horn resigns Omid Farokhzad became president and Charles Endweiss became principal financial officer and treasurer, effective October 1, 2026.

Growing. Revenue grew 2.5x in 4 years, from $6.6M in FY2021 to $16.6M in FY2025, about 26% a year.

Updated Proteograph products The newer report describes an updated assay and automation instrument within the Proteograph suite; the older report describes the suite as consumables, an instrument and software.

Who Do They Compete With?

Competes with Agilent Technologies, Bio-Techne, Bruker, Danaher, DiaSorin, Illumina, Thermo Fisher Scientific, Alamar Biosciences, Nautilus Biotechnology, Quanterix, and Quantum-Si

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support